JP Morgan maintains Overweight on Procter & Gamble, cuts target to $162
JP Morgan analyst Andrea Teixeira maintains an Overweight rating on Procter & Gamble but lowers the price target to $162 from $164, reflecting a revised outlook.
*this image is generated using AI for illustrative purposes only.
JP Morgan analyst Andrea Teixeira has maintained an Overweight rating on Procter & Gamble while lowering the price target to $162 from $164. The revised target indicates a slight recalibration of the stock's potential upside.
Rating and Price Target
The research note reaffirms a positive stance on Procter & Gamble despite the reduction in the price objective. The new target of $162 is down from the previous estimate of $164.
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $164 |
| New Price Target | $162 |
The adjustment comes as the firm evaluates the company's current valuation and market conditions.
What specific market conditions or valuation metrics prompted JP Morgan to lower the price target?
How might Procter & Gamble's upcoming earnings report influence the revised price target?
What are the key risks or opportunities that could impact Procter & Gamble's stock performance in the near term?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
